Becton Dickinson & Co. (BDX): Price and Financial Metrics

Becton Dickinson & Co. (BDX): $265.20

0.16 (+0.06%)

POWR Rating

Component Grades








BDX Price/Volume Stats

Current price $265.20 52-week high $287.32
Prev. close $265.04 52-week low $215.90
Day low $264.03 Volume 633,300
Day high $266.82 Avg. volume 1,164,011
50-day MA $272.72 Dividend yield 1.37%
200-day MA $255.76 Market Cap 76.94B

BDX Stock Price Chart Interactive Chart >


  • Stability is the dimension where BDX ranks best; there it ranks ahead of 88.91% of US stocks.
  • BDX's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • BDX ranks lowest in Momentum; there it ranks in the 21st percentile.

BDX Stock Summary

  • With a market capitalization of $76,754,025,423, BECTON DICKINSON & CO has a greater market value than 97.09% of US stocks.
  • BECTON DICKINSON & CO's stock had its IPO on January 1, 1986, making it an older stock than 93.16% of US equities in our set.
  • In terms of volatility of its share price, BDX is more volatile than only 6.87% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to BECTON DICKINSON & CO are MDT, DELL, A, CARR, and CSGP.
  • BDX's SEC filings can be seen here. And to visit BECTON DICKINSON & CO's official web site, go to

BDX Valuation Summary

  • BDX's EV/EBIT ratio is 41.2; this is 232.26% higher than that of the median Healthcare stock.
  • Over the past 243 months, BDX's EV/EBIT ratio has gone up 26.9.

Below are key valuation metrics over time for BDX.

Stock Date P/S P/B P/E EV/EBIT
BDX 2023-09-18 4.0 3.0 48.5 41.2
BDX 2023-09-15 4.0 2.9 48.4 41.1
BDX 2023-09-14 4.0 3.0 48.6 41.2
BDX 2023-09-13 4.0 3.0 48.6 41.3
BDX 2023-09-12 4.0 2.9 48.4 41.1
BDX 2023-09-11 4.1 3.0 49.0 41.6

BDX Growth Metrics

    Its 2 year price growth rate is now at 1.32%.
  • Its 3 year net income to common stockholders growth rate is now at 97.41%.
  • Its 4 year cash and equivalents growth rate is now at 345.07%.
BDX's revenue has moved up $1,587,000,000 over the prior 34 months.

The table below shows BDX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 18,999 2,359 1,520
2022-09-30 18,870 2,634 1,689
2022-06-30 19,782 2,612 1,666
2022-03-31 20,031 3,044 1,830
2021-12-31 19,927 3,788 1,676
2021-09-30 20,248 4,647 2,002

BDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BDX has a Quality Grade of C, ranking ahead of 56.62% of graded US stocks.
  • BDX's asset turnover comes in at 0.365 -- ranking 118th of 186 Medical Equipment stocks.
  • MYO, BTCY, and NURO are the stocks whose asset turnover ratios are most correlated with BDX.

The table below shows BDX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.365 0.470 0.103
2021-03-31 0.347 0.469 0.092
2020-12-31 0.337 0.458 0.088
2020-09-30 0.321 0.443 0.059
2020-06-30 0.320 0.451 0.053
2020-03-31 0.333 0.462 0.062

BDX Price Target

For more insight on analysts targets of BDX, see our BDX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $267.80 Average Broker Recommendation 1.58 (Moderate Buy)

Becton Dickinson & Co. (BDX) Company Bio

Becton, Dickinson and Company provides solutions which are focused on improving medication management and patient safety, supporting infection prevention practices, equipping surgical and interventional procedures, improving drug delivery, aiding anesthesiology and respiratory care, advancing cellular research and applications, enhancing the diagnosis of infectious diseases and cancers, and supporting the management of diabetes. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

BDX Latest News Stream

Event/Time News Detail
Loading, please wait...

BDX Latest Social Stream

Loading social stream, please wait...

View Full BDX Social Stream

Latest BDX News From Around the Web

Below are the latest news stories about BECTON DICKINSON & CO that investors may wish to consider to help them evaluate BDX as an investment opportunity.

Here's Why You Should Hold BD (BDX) Stock in Your Portfolio

BD's (BDX) slew of product launches raises optimism about the stock.

Yahoo | September 19, 2023

BD Ranks in Top 10 for Transparency, Awarded Best Code of Conduct in 2023 U.S. Transparency Awards

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been ranked in the top 10 for overall transparency and awarded Best Code of Conduct among S&P 250 companies in the fifth annual U.S. Transparency Awards by Labrador, a global communications firm specializing in corporate disclosures.

Yahoo | September 19, 2023

BD's (BDX) Tie-Up to Explore Flow Cytometry for Clinical Outcomes

BD's (BDX) latest partnership is likely to accelerate the delivery of innovative personalized therapies to patients who need them the most.

Yahoo | September 8, 2023

Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Yahoo | September 7, 2023

Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development

Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, announces a strategic collaboration with BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, to explore opportunities to develop and commercialize flow cytometry-based companion diagnostics and tools for clinical decisions.

Yahoo | September 7, 2023

Read More 'BDX' Stories Here

BDX Price Returns

1-mo -4.96%
3-mo 3.75%
6-mo 10.71%
1-year 15.04%
3-year 28.23%
5-year 10.97%
YTD 5.43%
2022 5.15%
2021 1.88%
2020 -6.75%
2019 22.20%
2018 6.61%

BDX Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BDX Dividend History

Continue Researching BDX

Here are a few links from around the web to help you further your research on Becton Dickinson & Co's stock as an investment opportunity:

Becton Dickinson & Co (BDX) Stock Price | Nasdaq
Becton Dickinson & Co (BDX) Stock Quote, History and News - Yahoo Finance
Becton Dickinson & Co (BDX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!